WHR
57
-5
DHI
52
2
EQR
37
3
WYNN
45
-3
GPC
56
2
LOW
36
2
UHS
43
-4
CA
9
-3
CNP
62
12
EFX
50
3
HP
32
2
O
35
2
ACN
40
4
COST
44
-3
NOV
40
-2
ROK
71
3
MCHP
73
4
WEC
53
5
NTRS
64
15
MTCH
53
2
WHR
57
-5
DHI
52
2
EQR
37
3
WYNN
45
-3
GPC
56
2
LOW
36
2
UHS
43
-4
CA
9
-3
CNP
62
12
EFX
50
3
HP
32
2
O
35
2
ACN
40
4
COST
44
-3
NOV
40
-2
ROK
71
3
MCHP
73
4
WEC
53
5
NTRS
64
15
MTCH
53
2
Financhill
Back

Amicus Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

FOLD
Amicus Therapeutics

Last Price:
$6.30
Seasonality Move:
3.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.4% based on the past 18 years of stock performance.
  • Amicus Therapeutics has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $6.07. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.4% based on the past 18 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
45
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
12.65
52-Week Low:
5.51

Prediction Charts

Market Cap:
1.9B
Price in USD:
6.07
Volume:
3.3M
Beta:
0.97

Technical Analysis

SMA50:
6.08
SMA100:
7.09
SMA200:
8.62
52-Wk Change:
-44%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 6.07 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 5.73 5.69 5.78 5.55
Jun-27 5.69 5.93 5.95 5.65
Jun-30 5.90 5.73 5.92 5.72
Jul-1 5.70 5.84 5.99 5.66
Jul-2 5.82 5.95 5.97 5.78
Jul-3 6.01 6.10 6.15 5.97
Jul-7 6.10 6.05 6.16 6.01
Jul-8 6.05 6.22 6.25 6.04
Jul-9 6.28 6.42 6.45 6.27
Jul-10 6.44 6.30 6.44 6.23
Jul-11 6.28 6.09 6.28 6.08
Jul-14 6.08 6.24 6.26 6.05
Jul-15 6.29 5.91 6.31 5.88
Jul-16 5.96 6.07 6.09 5.94

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.03 per share, an increase this year of $0.12 per share, and an increase next year of $0.34 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.